← FDA Drug Approvals (Drugs@FDA)

DOXYCYCLINE HYCLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2025-08-05

Drug application

FDA Application #

ANDA218888

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOXYCYCLINE HYCLATE

Generic name

DOXYCYCLINE

Active ingredients

DOXYCYCLINE HYCLATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ASPIRO

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2025-08-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown